Mark Heinen
Vermögen: 10 357 $ am 31.05.2026
Vermögen: 10 357 $ am 31.05.2026
Mark Heinen currently works at Volato Group, Inc., as Chief Financial Officer from 2023.
Mr. Heinen also formerly worked at Daegis, Inc., as Chief Financial Officer from 2013 to 2016, Trintech, Inc., as CFO & Senior VP-Global Corporate Controller from 2017 to 2019, Better Therapeutics, Inc., as Chief Financial Officer & Head-Finance from 2021 to 2023, and Omnigo LLC, as Chief Financial Officer.
Mr. Heinen received his undergraduate degree and Masters Business Admin degree from the University of Oklahoma.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0.2% | 21.04.2026 | 60’921 ( 0.2% ) | 10 357 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|
| Unternehmen | Position | Ende |
|---|---|---|
| BETTER THERAPEUTICS, INC. | Finanzdirektor/CFO | 27.11.2023 |
Trintech, Inc.
Trintech, Inc. Packaged SoftwareTechnology Services Provides account reconciliation and payment infrastructure software solutions | Finanzdirektor/CFO | 10.09.2019 |
| DAEGIS INC | Finanzdirektor/CFO | 01.01.2016 |
Omnigo LLC | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
University of Oklahoma
University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trintech, Inc.
Trintech, Inc. Packaged SoftwareTechnology Services Provides account reconciliation and payment infrastructure software solutions | Technology Services |
Daegis, Inc.
Daegis, Inc. Packaged SoftwareTechnology Services Provides application development, data management, migration and archiving software solutions | Technology Services |
Better Therapeutics, Inc.
Better Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases | Health Technology |
Omnigo LLC |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen